3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Plinabulin: new trials by email Literature Review of Plinabulin trials Research Report on Plinabulin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Nivolumab, Plinabulin, Ipilimumab - Lung Cancer, SCLC | Phase 1 / Phase 2 | Completed | Salma Sabbour | 39 | 2018-09-06 | 2026-01-20 |
| Plinabulin iv Solution in Prevention of TAC Induced Neutropenia Plinabulin, Pegfilgrastim, Docetaxel, doxorubicin, and cyclophosphamide (TAC) - Chemotherapy-induced Neutropenia | Phase 2 | Completed | BeyondSpring Pharmaceuticals Inc. | 115 | 2017-11-27 | 2020-01-18 |
| Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 Plinabulin, Pegfilgrastim - Chemotherapy-induced Neutropenia | Phase 2 | Completed | BeyondSpring Pharmaceuticals Inc. | 55 | 2017-04-05 | 2024-05-16 |
Lung Neoplasms (1)
BeyondSpring Pharmaceuticals Inc. (2) · Salma Sabbour (1)
China (2) · Ukraine (2) · United States (2) · Russia (1)